NAC1 is a transcriptional co-repressor protein that is essential to sustain cancer cell proliferation and migration. However, the underlying molecular mechanisms of NAC1 function in cancer cells remain unknown. In this study, we show that NAC1 functions as an actin monomer binding protein. The conserved BTB protein interaction domain in NAC1 is the minimal region for actin binding. Disrupting NAC1 complex function by dominant negative or siRNA strategies reduced cell retraction and abscission during late stage cytokinesis, causing multinucleation in cancer cells. In Nac1-deficient murine fibroblasts, restoring NAC1 expression was sufficient to partially avert multinucleation. We found that siRNA-mediated silencing of the actin binding protein profilin-1 in cancer cells caused a similar multinucleation phenotype and that NAC1 modulated the binding of actin to profillin-1. Taken together, our results indicate that the NAC1/actin/profilin-1 complex is crucial for cancer cell cytokinesis, with a variety of important biological and clinical implications.
Introduction
The Bric-a-Brac Tramtrack Broad complex (BTB) family of proteins shares a conserved BTB protein-protein interaction domain (1, 2) that is present in many DNA and actin binding proteins (3) . Nucleus accumbens-associated 1 (NAC1) encoded by NACC1 is a member of the family, and the gene was first identified by the observation that the level of NAC1 transcript was elevated in the rat nucleus accumbens in response to cocaine administration (4) . Subsequently, NAC1 has been shown to participate in diverse biological functions ranging from maintenance of stemness and proliferation of embryonic stem cells (5, 6) to the pathogenesis of human cancer (7) (8) (9) (10) (11) (12) . Like other members of the BTB family, the homodimeric or heterodimeric interaction mediated by its BTB domain is thought to be essential for the various functional activities of NAC1 (7) .
The biological role of NAC1 in cancer has recently emerged, as NAC1 has been found to be overexpressed in several types of human cancer including ovarian high-grade serous carcinoma, one of the most lethal neoplastic diseases in women (7, 8, (12) (13) (14) (15) . One of the mechanisms underlying NAC1 overexpression in ovarian cancer is amplification of the NAC1-encoded gene, NACC1, and analysis of The Cancer Genome Atlas (TCGA) data set demonstrates NACC1 as one of the top potential "driver" genes, showing the highest correlation between DNA and RNA copy number in ovarian high-grade serous carcinomas (11) . Moreover, NAC1 upregulation is associated with disease aggressiveness and contributes to the development of chemoresistance (9, 10, 16) . NAC1 is essential for survival and growth of ovarian cancer cells that overexpress NAC1, because NAC1-silencing or inactivation through ectopic expression of a deletion mutant containing only the BTB domain significantly reduced proliferation of ovarian cancer cells (7) (8) (9) (10) .
Molecular mechanisms underlying the essential role of NAC1 in cancer cell survival are thought to involve multiple pathways including activation of the Gadd45 cell survival pathway (8, 9) , fatty acid metabolism (17) , and the HMGB-1 (High-mobility group protein B1) mediated autophagic response (16) .
In addition, the possibility that NAC1 is also involved in non-nuclear functions is indicated by the dynamic changes in subcellular localization of NAC1 at different phases of cell cycle progression (18) . In non-mitotic cells, NAC1 accumulated in distinct nuclear punctate bodies, which were dissolved into a diffuse pattern of distribution in the cytoplasm during mitosis. NAC1 nuclear bodies immediately reappeared on completion of mitosis (18) , suggesting that NAC1 plays a role specifically during cell division. In this study we sought to investigate the role of NAC1 in cell division and to identify molecular mechanisms by which it contributes to the survival of tumor cells. Our results demonstrate that NAC1 is an actin monomer binding protein that regulates actin assembly in cancer cells during cytokinesis, a finding that provides a new perspective on the regulation of this fundamental biological process in tumor cells.
Materials and Methods

Traction force microscopy
The method for embedding 0.1 μm RFP (red fluorescent protein) methoxy fluorescent beads in the polymerized acrylamide substrate (0.1% methylene-bis-acrylamide and 5% acrylamide) was detailed in a previous report (19) and carried out on a glass bottom cell culture dish. A collagen layer was overlaid before SKOV3 N130 tTA cells were seeded in the dish at a suitable density for time-lapse imaging. An image frame was collected once every 10 minutes to minimize the deleterious effects related to the excitation beam, and to construct time-lapse videos for frame-by-frame measurements of the displacement of the beads. Photomicrographs were taken at 40x magnification to ensure sufficient resolution for resolving miniscule bead displacement using the 'Tracking' function in the Nikon Elements software. A total of 80 beads were tracked over the 3 conditions. The comparison of traction generated by the cells was accomplished by measuring maximal displacement of beads from origin along the x and y axis over time and plotting the data as a distribution.
Measurement of the contractile ring diameter
N130-induced and non-induced cells were fixed and stained for actin and DAPI. Dividing cells were randomly selected (n=20 for each condition) and the diameter of their contractile ring was directly measured using the ImageJ software (National Institutes of Health, Bethesda, Maryland).
Plotting of cell displacement trajectories
SKOV3 and HeLa cells seeded in collagen-coated plates were imaged at low magnification every 10 minutes overnight. Using the image recognition software 
Establishment of primary cell cultures
To establish a primary culture of mouse lung fibroblast in the NAC1 knockout genotype, lung tissue specimens were minced, digested using collagenase (10 μg/ml) at 37°C on a rotisserie rotator, and sieved to isolate single cells. Cells were cultured in RPMI 1640 supplemented with 10% (v/v) FBS and penicillin/streptomycin (Invitrogen).
To establish a primary culture of mouse ovarian surface epithelial cells (mOSE), we harvested the ovaries from female mice of about 10 weeks of age and the mOSE cells were dissociated from the ovarian surface after incubating with 0.25% trypsin-EDTA at 37°C for 30 minutes followed by gentle agitation. The mOSE cells were washed and plated in Dulbecco's modified Eagle's medium-F12 media (10% Fetal bovine serum, 5%
insulin-transferrin-selenium-A and 5% penicillin streptomycin) in a culture dish. Fresh media was replaced every 2-3 days and the cells were harvested at subconfluence for experimental purposes.
Generation of binding isotherm of NAC1/N130/Profilin-1 and actin
The construction of the binding isotherm was carried out (20) with actin at fixed low concentrations in supernatant, and using increasing amounts of NAC1 immobilized on anti-V5 beads to overcome the limited solubility of NAC1 in aqueous condition. The amount of actin in solution was quantified by high resolution scanning and processing by band densitometric analysis using the BioRad ChemiDoc XRS QuantityOne software in comparison to a standard curve based on actin input and silver staining.
Cell lines and culture conditions
The cell lines used in this study, including SKOV3, HeLa, MCF7, TOV21G and HEK293T, were purchased from ATCC (Rockville, MD, USA), authenticated with short tandem repeat (STR) based genotyping by the Fragment Analysis Facility at the Johns Hopkins University, and matched to their profiles at the ATCC STR profile database for human cell lines. Transfection was performed using the Lipofectamine-2000 reagent (Invitrogen). Nocodazole (100 ng/ml) was used to synchronize the cells at the mitotic phase. Nuclear and cytoplasmic purification of the lysates was carried out as described using the hypotonic swelling method; the purity of the nuclei were verified by microscopy (21).
Recombinant protein production
The NAC1-V5 construct was cloned into the pQE bacterial expression vector for recombinant protein production and purification using Ni-NTA beads (Qiagen). The insoluble protein was refolded using the Pierce protein refolding kit buffer 3 (Pierce) and immobilized on anti-V5 agarose beads (Sigma). Purified recombinant actin and profilin-1 were purchased from Cytoskeleton Inc. (Denver, CO). 
Results
NAC1 inactivation or silencing causes a multinucleation phenotype in cancer cells
In order to document the biological roles of NAC1 during cancer cell division, we used two independent and complementary approaches. First, we ectopically expressed a truncated NAC1 construct, N130, in SKOV3 human ovarian cancer cells and HeLa cells to competitively inhibit the functional activity of wild type NAC1. The N130 construct encodes exclusively the BTB domain, which is the minimal motif required for the homodimerization of NAC1; expression of N130 has been shown to competitively disrupt NAC1 homodimerization (7) . Following induction of N130 expression in SKOV3, an accumulation of polyploid cells at 4n was observed at 48 hours. After 72 hours, another distinct population of polyploid cells at 8n was detected (Fig. 1A) . By direct visualization using immunofluorescence staining, we found that the increase in DNA content corresponded to the increase in the number of multinucleated cells (Fig. 1B) . The induction of the BTB domain in HeLa cells caused a similar multinucleation phenotype (Supplementary Fig. S1A and S1B). The multinucleation induced by N130 induction was also accompanied by a significant reduction in cellular proliferation in SKOV3 cells (Fig.   1C ).
To control for potential non-specific effects related to N130 expression, we ectopically 1D ) nor induced multinucleation. We also performed RNAi to determine the specificity of N130-induced phenotypes. NAC1 expression was silenced using lentiviral shRNAs ( Supplementary Fig. S2A ), and like the effects of N130 induction, silencing of NAC1 in SKOV3 and HeLa cells caused multinucleation in cancer cells (SKOV3: Fig. 1E ; HeLa: Supplementary Fig. S2B, S2C ). We also found that shRNAs targeting NAC1 suppressed cellular proliferation in SKOV3, HeLa, and MCF7 cancer cells ( Supplementary Fig.   S2D ), all of which express abundant NAC1 ( Supplementary Fig. S2E ), whereas NAC1 shRNA expression in the TOV21G tumor cell line, which has undetectable NAC1 expression (10), had a less conspicuous effect. 
Expression of NAC1 partially rescues normal cytokinesis in Nac1-null cells
To determine if NAC1 was essential for effective cytokinesis, we re-introduced NAC1 expression in Nac1-null cells to determine whether ectopic NAC1 would prevent the multinucleated phenotype. For this purpose, we utilized a Nac1 homozygous knockout (Nac1 -/-) mouse in which both copies of the BTB domain of the mouse Nacc1 gene were deleted (Fig. 4A ). In addition, we bred Nac1 hemizygous knockout mice (Nac1 (Fig. 4C and 4D ).
To determine if the re-expression of Nac1 protein could rescue the multinucleation phenotype, NAC1 was re-introduced into Nac1 -/-cells as a V5-NAC1 protein by a retroviral vector. We then quantified the number of multinucleated cells in cultures that were either treated with control virus (n=329) or with the NAC1 expression construct virus (n=304). We found that there was a significant reduction (28.3% to 6.25%) in the percentage of multinucleated cells after the introduction of the NAC1 expression vector (Fig. 4E) . The successful introduction of NAC1 expression was confirmed by immunofluorescence detection of the V5 epitope (Fig. 4F ) and by Western blot (Fig. 4G) .
A similar result could be obtained in mouse ovarian surface epithelial (mOSE) cells generated from the same strain of mice ( Supplementary Fig. S5 ).
Cancer cells after profilin-1 silencing exhibit a similar multinucleation phenotype
The multinucleation phenotype observed in NAC1 inactivated or silenced cells is reminiscent of multinucleation reported in mouse chondrocytes after silencing of profilin-1 (19) . In the current study, by silencing profilin-1 expression ( Supplementary Fig. S6A ),
we were able to demonstrate the formation of multinucleated cells in SKOV3 cells ( Next, using immunofluorescence microscopy we found that NAC1 and profilin-1 colocalized during cell division in HeLa cells (Fig. 5B ). Nuclear and cytoplasmic protein extracts from HeLa and MCF7 cells were used for Western blot analysis to analyze the distribution of the proteins in the cellular compartments. Interestingly, NAC1 was mainly found in the nuclear extract during interphase, with low levels in the cytoplasm, while profilin-1 was almost exclusively detected in the cytoplasmic extract (Fig. 5C ). When we mitotically arrested cells with the microtubule-depolymerizing drug, nocodazole, and examined NAC1 levels by Western blot in the cytoplasmic fraction, we found that there was a significant amount of NAC1 in the cytoplasmic fraction as compared to the chromosomal fraction (Supplementary Fig. S6E ). This cell cycle dependent localization of NAC1 was previously described in an earlier publication (18) . Thus, during cell 
division NAC1 abundantly accumulated in the cytoplasm where it may colocalize with profilin-1.
Accordingly, co-immunoprecipitation experiments were conducted to determine whether NAC1 and profilin-1 interacted in vivo. We found that endogenous NAC1 and profilin-1 could be co-immunoprecipitated from lysates prepared from HeLa and MCF7 cells (Fig.   5D ). Both HeLa and MCF7 cells have abundant NAC1 expression as previously documented ( Supplementary Fig. S2E ). Reciprocal co-immunoprecipitation experiments using anti-profilin-1 for pull-down and anti-NAC1 for Western blot detection confirmed that NAC1 and profilin-1 were constituents of the same protein complexes.
NAC1 interacts directly with actin monomers
As profilin-1 is an actin binding protein and plays a pivotal role in actin polymerization (23), we investigated the possibility that NAC1 also interacted with actin. Coimmunoprecipitation experiments using cytoplasmic extracts of MCF7 cells demonstrated that NAC1 co-immunoprecipitated with actin monomers in cytoplasmic but not in nuclear lysates (Fig. 6A) . To further determine if the NAC1-actin interaction was direct or depended on profilin-1, we performed an in vitro binding assay using NAC1-V5, profilin-1, and actin recombinant proteins. After incubating NAC1-V5 and actin, we observed that actin could be co-eluted with NAC1 on anti-V5 agarose beads. In the absence of NAC1-V5 protein, however, actin was not retained on the anti-V5 beads and was undetectable in the eluted protein fraction (Fig. 6B) . We also conducted quantitative binding assays using a method previously described (20) 
interactions (actin standard curve documented in Supplementary Fig. S7A) . A fixed amount of actin or profilin-1 protein was incubated with increasing amounts of NAC1-V5-beads. After incubation, the amount of unbound actin or profilin-1 in the supernatant was measured and used to determine the bound fraction. We found that recombinant NAC1 was unable to demonstrate a dose-dependent co-binding of profilin-1 in the binding affinity assay (Supplementary Fig. S7B ). On the other hand, we were able to demonstrate the dose-dependent binding of NAC1 and actin in the binding affinity assay (Fig. 6C) . Taken together, these results indicated a direct protein-protein interaction between NAC1 and actin, but not between NAC1 and profilin-1, although in vivo coimmunoprecipitation reactions (Fig. 5D ) demonstrated NAC1 and profilin-1 are in the same protein complexes.
The quantitative binding assays performed found that NAC1-V5 and actin interacted with a K d of 0.78 μM (Fig. 6C) . As a negative control, an irrelevant protein of similar molecular weight as NAC1, Notch3-ICD-V5 was analyzed in parallel to demonstrate the assay specificity (Supplementary Fig. S7C ). To determine the domain of the NAC1 protein that was involved in the direct interaction with actin, we generated another recombinant NAC1 protein composed of only the BTB domain (N130-V5). We carried out a similar quantitative binding assay between N130-V5 and actin. These proteins bound with a K d of 0.52 μM (Fig. 6D) . To further support the finding that the BTB domain of NAC1 was responsible for its interaction with the actin, we used a series of NAC1 deletion mutants ( Supplementary Fig. S8A ), and were able to confirm that the BTB domain of NAC1 ( Supplementary Fig. S8C1 ) was responsible for its interaction with the profilin-1/actin complex.
NAC1 is able to modulate binding between profilin-1 and actin monomers
Because the interaction between actin and profilin-1 is known to be critical for cytokinesis (22), our results suggested that the interaction between NAC1 and actin could modulate the binding between profilin-1 and actin. We employed Nac1 -/-lung fibroblasts as a cellular system to test this hypothesis. Due to the relatively high binding affinity between actin and profilin-1, we created a profilin-1 mutant, PFN1 Y60A , which has been demonstrated to exhibit reduced actin binding activity (25) . We also generated PFN1 R89L , a control that does not affect the binding between profilin-1 and actin (26) (Fig. 7A 
Discussion
The results from the current study unveil a novel mechanism by which cancer cells facilitate their incessant cellular divisions, which is the cardinal feature of neoplastic diseases. Our results indicate that abundant NAC1 proteins in cancer cells promote cytokinesis through modulating the interaction of actin and profilin-1, ensuring an effective completion of cellular division in highly proliferative tumors. The observation that NAC1 overexpressing tumor cells develop molecular dependence on NAC1 protein (7-9) promises future exploitation by targeting NAC1 as a cytostatic cancer therapy aimed at compromising cytokinesis in cancer cells.
Cytokinesis is a highly complex event involving a cascade of sequential and highly coordinated molecular processes (27) . In eukaryotic cells, this is made possible by chromosomal segregation and Rho GTPase signaling followed by the effective assembly and constriction of contractile rings by non-muscle myosin II, actin, and its binding partners before actual cellular division occurs (27) (28) (29) . For example, disruption of Rho GTPase signaling, which is known to regulate the actin cytoskeleton, can result in the misalignment of the cleavage furrow and contractile ring (30) . Cytokinesis failure can also result from the slow ring closure of the contractile apparatus due to inadequate constriction, leading to a cytoplasmic connection between daughter cells that precedes furrow regression (31) . As shown in this study, inactivation or silencing of NAC1 did not move the dividing cells apart to make the "final cut", impeding abscission and resulting in incomplete partitioning of the cytoplasm of the cell (29) . This finding is consistent with previous studies demonstrating that traction force is required for complete cytokinesis in dividing cells in Dictyostelium and mouse chondrocytes (19, 27) .
The actin binding property of NAC1 and its ability to modulate the interaction between profilin-1 and actin may account for the defective cytokinesis observed in tumor cells after NAC1 inactivation or knockdown. Since actin structures have been shown to be important for the regulation of cell shape and movement (Pollard and Cooper, 2009 ), the demonstration that NAC1 is an actin binding protein could also explain previously reported findings that reducing NAC1 expression by RNA interference decreased cellular motility (10, 32) . Apropos to these observations, it has been well established that profilin-1, which is a ubiquitous actin monomer-binding protein, regulates actin polymerization in response to various extracellular signals by catalyzing ADP-to-ATP exchange on G-actin and escorting actin monomers to the growing barbed ends of actin filaments (23, 24) .
Profilin-1 has been thought to be a key component of the core cytokinesis machinery (19, 22, 33) . The fact that NAC1 and profilin-1 co-exist in the same actin complex and that the same phenotype, i.e., incomplete cytokinesis followed by multinucleation, is produced by knockdown of either gene argues that NAC1 plays a role similar to profilin- This finding is of great interest in light of the lack of actin-targeting agents in the arsenal of anti-cancer drugs, a consequence of the fact that the known reagents target the actin assembly in both cancer and normal cells (35) . That disrupting NAC1 BTB domain protein interactions as a cancer chemotherapeutic strategy is feasible is suggested by the use of peptidomimetic and small molecule inhibitors to disrupt the BTB interacting domain of BCL6, which has been shown to be effective in suppressing tumor growth in B cell lymphomas (36-38). Triggering cytokinesis failure in cancer cells could give rise to either chromosomal instability or apoptosis. However, it is expected that in the presence of the functional p53, cells that were treated with drugs blocking cytokinesis will acquire extreme polyploidy and undergo rapid cell death or senescence (31, 39) .
In summary, our findings provide cogent evidence that NAC1 is a member of the actin-binding protein family. The potential involvement of NAC1 in regulating actin organization during late stage cytokinesis represents a functional property well beyond its 
